Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Itm2a expression marks periosteal skeletal stem cells that contribute to bone fracture healing
Wenhui Xing, … , Bo O. Zhou, Weiguo Zou
Wenhui Xing, … , Bo O. Zhou, Weiguo Zou
Published September 3, 2024
Citation Information: J Clin Invest. 2024;134(17):e176528. https://doi.org/10.1172/JCI176528.
View: Text | PDF
Research Article Bone biology

Itm2a expression marks periosteal skeletal stem cells that contribute to bone fracture healing

  • Text
  • PDF
Abstract

The periosteum contains skeletal stem/progenitor cells that contribute to bone fracture healing. However, the in vivo identity of periosteal skeletal stem cells (P-SSCs) remains unclear, and membrane protein markers of P-SSCs that facilitate tissue engineering are needed. Here, we identified integral membrane protein 2A (Itm2a) enriched in SSCs using single-cell transcriptomics. Itm2a+ P-SSCs displayed clonal multipotency and self-renewal and sat at the apex of their differentiation hierarchy. Lineage-tracing experiments showed that Itm2a selectively labeled the periosteum and that Itm2a+ cells were preferentially located in the outer fibrous layer of the periosteum. The Itm2a+ cells rarely expressed CD34 or Osx, but expressed periosteal markers such as Ctsk, CD51, PDGFRA, Sca1, and Gli1. Itm2a+ P-SSCs contributed to osteoblasts, chondrocytes, and marrow stromal cells upon injury. Genetic lineage tracing using dual recombinases showed that Itm2a and Prrx1 lineage cells generated spatially separated subsets of chondrocytes and osteoblasts during fracture healing. Bone morphogenetic protein 2 (Bmp2) deficiency or ablation of Itm2a+ P-SSCs resulted in defects in fracture healing. ITM2A+ P-SSCs were also present in the human periosteum. Thus, our study identified a membrane protein marker that labels P-SSCs, providing an attractive target for drug and cellular therapy for skeletal disorders.

Authors

Wenhui Xing, Heng Feng, Bo Jiang, Bo Gao, Jiping Liu, Zaiqi Xie, Yazhuo Zhang, Xuye Hu, Jun Sun, Matthew B. Greenblatt, Bo O. Zhou, Weiguo Zou

×

Figure 1

scRNA-Seq analysis shows that Itm2a can enrich SSCs in Prrx1 lineage periosteal cells.

Options: View larger image (or click on image) Download as PowerPoint
scRNA-Seq analysis shows that Itm2a can enrich SSCs in Prrx1 lineage per...
(A) The isolation and scRNA-Seq workflow of Ai9+ periosteal cells from Prrx1-Cre R26-Ai9 mice. (B) t-SNE plot of collected Ai9+ cells. Cells were clustered into 13 subpopulations: stem/progenitor cells (clusters 0–3, 7, and 10), osteoblasts (clusters 4 and 12), ECs (clusters 5, 6, and 8), and muscle cells (clusters 9 and 11). (C–F) Feature plots showing the representative marker distribution in different cell types: periosteal stem/progenitor cells (Col3a1 and Itgbl1) (C), osteoblasts (Sp7 and Bglap) (D), muscle cells (Pax7 and Myob5) (E), and ECs (Emcn and Pecam1) (F). (G and H) Pseudotime analysis of the 3 states of Ai9+ cells. (I) Feature plots of CD105 and CD200 expression in Ai9+ cells. (J) t-SNE plot of the periosteal stem/progenitor cells (state 2, clusters 0, 1, 2, 3, 7, and 10). (K) Feature plots showing the distribution of Itm2a in P-SSCs. (L) Flow cytometric analysis of SSCs and progenitors in the murine periosteum. (M) Percentage of SSCs in Itm2a+ and Itm2a– cell populations. Data are presented as the mean ± SD. n = 3. ***P < 0.001, by unpaired t test.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts